Sponsor or institution

Clinical trials and research at Antengene Corporation

• 5Clinical trials
• 2Countries

Newest trials

All recruiting trials (5)

• ATG-022 vs investigator's choice for CLDN18.2-positive advanced gastric/GEJ cancer

  This trial tests ATG-022 against the doctor’s choice of treatment in adults whose advanced gastric or gastroesophageal junction cancer has CLDN18.2 and who have already tried at least two prior therapies.

  Recruiting Phase 3 Antengene Corporation · Bengbu, Anhui and 130 other locations · NCT07795346

• ATG-201 in adults with autoimmune diseases

  This early, open-label study tests ATG-201 in adults with autoimmune diseases to see if it is safe and tolerable, and to get initial clues about how the body handles the drug and its effects.

  Recruiting Phase 1 Antengene Corporation · Bengbu, Anhui and 21 other locations · NCT07732309

• ATG-022 plus pembrolizumab, with or without CAPOX chemotherapy, for CLDN18.2-positive, HER2-negative advanced stomach or gastroesophageal junction cancer

  This trial will try ATG-022 together with pembrolizumab, with or without CAPOX chemotherapy, to see if it helps people with CLDN 18.2-positive, HER2-negative advanced or metastatic gastric or gastroesophageal junction cancer who are PD-L1 positive.

  Recruiting at 26 sites Phase 1/2 Antengene Corporation · Hefei, Anhui and 29 other locations · NCT07327229

• Testing ATG-022 for advanced solid tumors

  This study is testing a new treatment called ATG-022 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 21 sites Phase 1 Antengene Corporation · Adelaide and 21 other locations · NCT05718895

• Assessing ATG-037 and Pembrolizumab for Advanced Solid Tumors

  This study is testing a new treatment called ATG-037, both alone and with Pembrolizumab, to see if it can help people with advanced solid tumors.

  Recruiting at 5 sites Phase 1 Antengene Corporation · Sydney, New South Wales and 7 other locations · NCT05205109

Quick answers

How many clinical trials run by Antengene Corporation are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (5 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →